1,740
Views
45
CrossRef citations to date
0
Altmetric
Review

Cannabis use and acute coronary syndrome

ORCID Icon, , , ORCID Icon, , & show all
Pages 831-841 | Received 09 Dec 2018, Accepted 25 Mar 2019, Published online: 09 Apr 2019

References

  • United Nations Office on Drugs and Crime (UNODC). World Drug Report 2018; [cited 2018 Dec 2]. Available from: https://www.unodc.org/wdr2018/prelaunch/WDR18_Booklet_1_EXSUM.pdf.
  • Pacher P, Steffens S, Haskó G, et al. Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly. Nat Rev Cardiol. 2018;15:151–166.
  • Jouanjus E, Raymond V, Lapeyre-Mestre M, et al. What is the current knowledge about the cardiovascular risk for users of cannabis-based products? A systematic review. Curr Atheroscler Rep. 2017;19:26.
  • Beaconsfield P, Ginsburg J, Rainsbury R. Marihuana smoking. Cardiovascular effects in man and possible mechanisms. N Engl J Med. 1972;287:209–212.
  • Johnson S, Domino EF. Some cardiovascular effects of marihuana smoking in normal volunteers. Clin Pharmacol Ther. 1971;12:762–768.
  • Kiplinger GF, Manno JE, Rodda BE, et al. Dose-response analysis of the effects of tetrahydrocannabinol in man. Clin Pharmacol Ther. 1971;12:650–657.
  • Kanakis C Jr, Pouget JM, Rosen KM. The effects of delta-9-tetrahydrocannabinol (cannabis) on cardiac performance with and without beta blockade. Circulation. 1976;53:703–707.
  • Aronow WS, Cassidy J. Effect of marihuana and placebo-marihuana smoking on angina pectoris. N Engl J Med. 1974;291:65–67.
  • Aronow WS, Cassidy J. Effect of smoking marihuana and of a high-nicotine cigarette on angina pectoris. Clin Pharmacol Ther. 1975;17:549–554.
  • Prakash R, Aronow WS, Warren M, et al. Effects of marihuana and placebo marihuana smoking on hemodynamics in coronary disease. Clin Pharmacol Ther. 1975;18:90–95.
  • Richards JR. Cannabinoid hyperemesis syndrome: a disorder of the HPA axis and sympathetic nervous system? Med Hypotheses. 2017;103:90–95.
  • Benowitz NL, Rosenberg J, Rogers W, et al. Cardiovascular effects of intravenous delta-9-tetrahydrocannabinol: autonomic nervous mechanisms. Clin Pharmacol Ther. 1979;25:440–446.
  • Liu J, Gao B, Mirshahi F, et al. Functional CB1 cannabinoid receptors in human vascular endothelial cells. Biochem J. 2000;346: 835–840.
  • Pacher P, Mechoulam R. Is lipid signaling through cannabinoid 2 receptors part of a protective system? Prog Lipid Res. 2011;50:193–211.
  • Wu TC, Tashkin DP, Djahed B, et al. Pulmonary hazards of smoking marijuana as compared with tobacco. N Engl J Med. 1988;318:347–351.
  • Yuan M, Kiertscher SM, Cheng Q, et al. Delta 9-tetrahydrocannabinol regulates Th1/Th2 cytokine balance in activated human T cells. J Neuroimmunol. 2002;133:124–131.
  • Sugamura K, Sugiyama S, Nozaki T, et al. Activated endocannabinoid system in coronary artery disease and antiinflammatory effects of cannabinoid 1 receptor blockade on macrophages. Circulation. 2009;119:28–36.
  • Lipina C, Hundal HS. Modulation of cellular redox homeostasis by the endocannabinoid system. Open Biol. 2016;6:150276.
  • Dahdouh Z, Roule V, Lognoné T, et al. Cannabis and coronary thrombosis: what is the role of platelets? Platelets. 2012;23:243–245.
  • Williams JC, Klein TW, Goldberger BA, et al. Δ(9)-Tetrahydrocannabinol (THC) enhances lipopolysaccharide-stimulated tissue factor in human monocytes and monocyte-derived microvesicles. J Inflamm (Lond). 2015;12:39.
  • Deusch E, Kress HG, Kraft B, et al. The procoagulatory effects of delta-9-tetrahydrocannabinol in human platelets. Anesth Analg. 2004;99:1127–1130.
  • Lehavi A, Shay M, Gilony C, et al. Marijuana smoking and paroxysmal atrial fibrillation. Harefuah. 2005;144:2–3, 72.
  • Baranchuk A, Johri AM, Simpson CS, et al. Ventricular fibrillation triggered by marijuana use in a patient with ischemic cardiomyopathy: a case report. Cases J. 2008;1:373.
  • Brancheau D, Blanco J, Gholkar G, et al. Cannabis induced asystole. J Electrocardiol. 2016;49:15–17.
  • Moher D, Liberati A, Tetzlaff J, The PRISMA Group, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. PLoS Med. 2009;6:e1000097.
  • Oxford Centre for Evidence-Based Medicine. Levels of Evidence. [cited 2018 Dec 2]. Available from: https://www.cebm.net/2009/06/oxford-centre-evidence-based-medicine-levels-evidence-march-2009.
  • Nawrot TS, Perez L, Künzli N, et al. Public health importance of triggers of myocardial infarction: a comparative risk assessment. Lancet. 2011;377:732–740.
  • Desbois AC, Cacoub P. Cannabis-associated arterial disease. Ann Vasc Surg. 2013;27:996–1005.
  • Pradhan RR, Pradhan SR, Mandal S, et al. A systematic review of marijuana use and outcomes in patients with myocardial infarction. Cureus. 2018;10:e3333.
  • Ravi D, Ghasemiesfe M, Korenstein D, et al. Associations between marijuana use and cardiovascular risk factors and outcomes: a systematic review. Ann Intern Med. 2018;168:187–194.
  • Sidney S, Beck JE, Tekawa IS, et al. Marijuana use and mortality. Am J Public Health. 1997;87:585–590.
  • James LP, Farrar HC, Komoroski EM, et al. Sympathomimetic drug use in adolescents presenting to a pediatric emergency department with chest pain. J Toxicol Clin Toxicol. 1998;36:321–328.
  • Mittleman MA, Lewis RA, Maclure M, et al. Triggering myocardial infarction by marijuana. Circulation. 2001;103:2805–2809.
  • Mukamal KJ, Maclure M, Muller JE, et al. An exploratory prospective study of marijuana use and mortality following acute myocardial infarction. Am Heart J. 2008;155:465–470.
  • Frost L, Mostofsky E, Rosenbloom JI, et al. Marijuana use and long-term mortality among survivors of acute myocardial infarction. Am Heart J. 2013;165:170–175.
  • Reece AS, Norman A, Hulse GK. Cannabis exposure as an interactive cardiovascular risk factor and accelerant of organismal ageing: a longitudinal study. BMJ Open. 2016;6:e011891.
  • Zaurova M, Hoffman RS, Vlahov D, et al. Clinical effects of synthetic cannabinoid receptor agonists compared with marijuana in emergency department patients with acute drug overdose. J Med Toxicol. 2016;12:335–340.
  • Auer R, Sidney S, Goff D, et al. Lifetime marijuana use and subclinical atherosclerosis: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Addiction. 2018;113:845–856.
  • Draz EI, Oreby MM, Elsheikh EA, et al. Marijuana use in acute coronary syndromes. Am J Drug Alcohol Abuse. 2017;43:576–582.
  • Reis JP, Auer R, Bancks MP, et al. Cumulative lifetime marijuana use and incident cardiovascular disease in middle age: The Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Public Health. 2017;107:601–606.
  • Yankey BA, Rothenberg R, Strasser S, et al. Effect of marijuana use on cardiovascular and cerebrovascular mortality: a study using the National Health and Nutrition Examination Survey linked mortality file. Eur J Prev Cardiolog. 2017;24:1833–1840.
  • Jouanjus E, Leymarie F, Tubery M, et al. Cannabis-related hospitalizations: unexpected serious events identified through hospital databases. Br J Clin Pharmacol. 2011;71:758–765.
  • Jouanjus E, Lapeyre-Mestre M, Micallef J, French Association of the Regional Abuse and Dependence Monitoring Centres (CEIP-A) Working Group on Cannabis Complications*. Cannabis use: signal of increasing risk of serious cardiovascular disorders. J Am Heart Assoc. 2014;3:e000638.
  • Thankavel PP, Mir A, Ramaciotti C. Elevated troponin levels in previously healthy children: value of diagnostic modalities and the importance of a drug screen. Cardiol Young. 2014;24:283–289.
  • Dines AM, Wood DM, Galicia M, Euro-DEN Research Group, et al. Presentations to the emergency department following cannabis use–a multi-centre case series from ten European countries. J Med Toxicol. 2015;11:415–421.
  • Desai R, Patel U, Sharma S, et al. Recreational marijuana use and acute myocardial infarction: insights from nationwide inpatient sample in the United States. Cureus. 2017;9:e1816.
  • Lee J, Sharma N, Aponte CS, et al. Clinical characteristics and angiographic findings of myocardial infarction among marijuana users and non-users. Scifed J Cardiol. 2017;1:pii: 1000008.
  • Lorenz DR, Dutta A, Mukerji SS, et al. Marijuana use impacts midlife cardiovascular events in HIV-infected men. Clin Infect Dis. 2017;65:626–635.
  • Sharma N, Lee J, Aponte CS, et al. Clinical characteristics and angiographic findings of acute myocardial infarction associated with marijuana use: consecutive case series. Scifed J Cardiol. 2017;2:pii: 1000011.
  • Abouk R, Adams S. Examining the relationship between medical cannabis laws and cardiovascular deaths in the US. Int J Drug Policy. 2018;53:1–7.
  • DeFilippis EM, Singh A, Divakaran S, et al. Cocaine and marijuana use among young adults with myocardial infarction. J Am Coll Cardiol. 2018;71:2540–2551.
  • Johnson-Sasso CP, Tompkins C, Kao DP, et al. Marijuana use and short-term outcomes in patients hospitalized for acute myocardial infarction. PLoS One. 2018;13:e0199705.
  • Kalla A, Krishnamoorthy PM, Gopalakrishnan A, et al. Cannabis use predicts risks of heart failure and cerebrovascular accidents: results from the National Inpatient Sample. J Cardiovasc Med. 2018;19:480–484.
  • Patel RS, Katta SR, Patel R, et al. Cannabis use disorder in young adults with acute myocardial infarction: trend inpatient study from 2010 to 2014 in the United States. Cureus. 2018;10:e3241.
  • Ramphul K, Mejias SG, Joynauth J. Cocaine, amphetamine, and cannabis use increases the risk of acute myocardial infarction in teenagers. Am J Cardiol. 2019;123:354.
  • Charles R, Holt S, Kirkham N. Myocardial infarction and marijuana. Clin Toxicol. 1979;14:433–438.
  • MacInnes DC, Miller KM. Fatal coronary artery thrombosis associated with cannabis smoking. J R Coll Gen Pract. 1984;34:575–576.
  • Collins JS, Higginson JD, Boyle DM, et al. Myocardial infarction during marijuana smoking in a young female. Eur Heart J. 1985;6:637–638.
  • Choi YS, Pearl WR. Cardiovascular effects of adolescent drug abuse. J Adolesc Health Care. 1989;10:332–327.
  • Podczeck A, Frohner K, Steinbach K. Acute myocardial infarction in juvenile patients with normal coronary arteries. Int J Cardiol. 1991;30:359–361.
  • Bachs L, Mørland H. Acute cardiovascular fatalities following cannabis use. Forensic Sci Int. 2001;124:200–203.
  • McLeod AL, McKenna CJ, Northridge DB. Myocardial infarction following the combined recreational use of viagra and cannabis. Clin Cardiol. 2002;25:133–134.
  • Rezkalla SH, Sharma P, Kloner RA. Coronary no-flow and ventricular tachycardia associated with habitual marijuana use. Ann Emerg Med. 2003;42:365–369.
  • Caldicott DG, Holmes J, Roberts-Thomson KC, et al. Keep off the grass: marijuana use and acute cardiovascular events. Eur J Emerg Med. 2005;12:236–244.
  • Fisher BA, Ghuran A, Vadamalai V, et al. Cardiovascular complications induced by cannabis smoking: a case report and review of the literature. Emerg Med J. 2005;22:679–680.
  • Lindsay AC, Foale RA, Warren O, et al. Cannabis as a precipitant of cardiovascular emergencies. Int J Cardiol. 2005;104:230–232.
  • Taher AT, Mahfouz RA, Otrock ZK, et al. Acute myocardial infarction in a young man: a consequence of inherited thrombophilia and marijuana smoking. Thromb Haemost. 2006;95:1044.
  • Tatli E, Yilmaztepe M, Altun G, et al. Cannabis-induced coronary artery thrombosis and acute anterior myocardial infarction in a young man. Int J Cardiol. 2007;120:420–422.
  • Cappelli F, Lazzeri C, Gensini GF, et al. Cannabis: a trigger for acute myocardial infarction? A case report. J Cardiovasc Med. 2008;9:725–728.
  • Dwivedi S, Kumar V, Aggarwal A. Cannabis smoking and acute coronary syndrome: two illustrative cases. Int J Cardiol. 2008;128:e54–e57.
  • Basnet S, Mander G, Nicolas R. Coronary vasospasm in an adolescent resulting from marijuana use. Pediatr Cardiol. 2009;30:543–545.
  • Sattout AH, Nicol MF. Cardiac arrest following cannabis use: a case report. Cases J. 2009;2:208.
  • Bailly C, Merceron O, Hammoudi N, et al. Cannabis induced acute coronary syndrome in a young female. Int J Cardiol. 2010;143:e4–e6.
  • Bilbault P, Duja CM, Bornemann JY, et al. Chest pain in young people: is cannabis a risk factor? J Emerg Trauma Shock. 2010;3:307.
  • Karabulut A, Cakmak M. ST segment elevation myocardial infarction due to slow coronary flow occurring after cannabis consumption. Kardiol Pol. 2010;68:1266–1268.
  • Canga Y, Osmonov D, Karataş MB, et al. Cannabis: a rare trigger of premature myocardial infarction. Anadolu Kardiyol Derg. 2011;11:272–274.
  • De Silva K, Perera D. Cannabis, collaterals, and coronary occlusion. Case Rep Cardiol. 2011;2011:469850.
  • Arora S, Goyal H, Aggarwal P, et al. ST-segment elevation myocardial infarction in a 37-year-old man with normal coronaries–it is not always cocaine! Am J Emerg Med. 2012;30:2091.e3–2095.
  • Biyik I, Akturk I, Yalcin A, et al. Cannabis joint triggered recurrent anterior myocardial infarction in an adolescent taking dual anti-platelet therapy. Int J Cardiol. 2012;155:S177–S178.
  • Safaa AM, Markham R, Jayasinghe R. Marijuana-induced recurrent acute coronary syndrome with normal coronary angiograms. Drug Alcohol Rev. 2012;31:91–94.
  • Yurtdaş M, Aydın MK. Acute myocardial infarction in a young man; fatal blow of the marijuana: a case report. Korean Circ J. 2012;42:641–645.
  • Casier I, Vanduynhoven P, Haine S, et al. Is recent cannabis use associated with acute coronary syndromes? An illustrative case series. Acta Cardiol. 2014;69:131–136.
  • Deharo P, Massoure PL, Fourcade L. Exercise-induced acute coronary syndrome in a 24-year-old man with massive cannabis consumption. Acta Cardiol. 2013;68:425–428.
  • Ghannem M, Belhadj I, Tritar A, et al. Cannabis and acute coronary syndrome with ST segment elevation. Ann Cardiol Angeiol. 2013;62:424–428.
  • Lee KB, Song BG, Kang GH, et al. Cannabis smoking and sildenafil citrate induced acute coronary syndrome in a patient with myocardial bridge. Anadolu Kardiyol Derg. 2013;13:180–181.
  • Sayın MR, Akpınar İ, Çetiner MA, et al. Diffuse coronary ectasia and acute coronary syndrome in a young man. Who is guilty? Cannabis, smoking or dyslipidemia? Anadolu Kardiyol Derg. 2013;13:616–618.
  • Gunawardena MD, Rajapakse S, Herath J, et al. Myocardial infarction following cannabis induced coronary vasospasm. BMJ Case Rep. 2014;doi: 10.1136/bcr-2014-207020.
  • Hartung B, Kauferstein S, Ritz-Timme S, et al. Sudden unexpected death under acute influence of cannabis. Forensic Sci Int. 2014;237:e11–e13.
  • Hodcroft CJ, Rossiter MC, Buch AN. Cannabis-associated myocardial infarction in a young man with normal coronary arteries. J Emerg Med. 2014;47:277–281.
  • Rodríguez-Castro CE, Alkhateeb H, Elfar A, et al. Recurrent myopericarditis as a complication of marijuana use. Am J Case Rep. 2014;15:60–62.
  • Jehangir W, Stanton M, Khan R, et al. Did cannabis precipitate an STEMI in a young woman? Cardiol Res. 2015;6:283–285.
  • Marchetti D, Spagnolo A, De Matteis V, et al. Coronary thrombosis and marijuana smoking: a case report and narrative review of the literature. Drug Test Anal. 2016;8:56–62.
  • Velibey Y, Sahin S, Tanık O, et al. Acute myocardial infarction due to marijuana smoking in a young man: guilty should not be underestimated. Am J Emerg Med. 2015;33:1114.e1–1113.
  • Hayiroglu MI, Kaya A, Avsar S, et al. Intracoronary thrombus in an 18-year-old teenager. Why? Hong Kong Med J. 2016;22:396–398.
  • Keskin M, Hayıroğlu Mİ, Keskin Ü, et al. Acute myocardial infarction and ischemic stroke coexistence due to marijuana abuse in an adolescent. Anatol J Cardiol. 2016;16:542–543.
  • Orsini J, Blaak C, Rajayer S, et al. Prolonged cardiac arrest complicating a massive ST-segment elevation myocardial infarction associated with marijuana consumption. J Community Hosp Intern Med Perspect. 2016;6:31695.
  • Pierard S, Hantson P. Coronary vasospasm complicating cannabinoid hyperemesis syndrome. J Cardiol Cases. 2017;15:115–118.
  • Del Buono MG, O'Quinn MP, Garcia P, et al. Cardiac arrest due to ventricular fibrillation in a 23-year-old woman with broken heart syndrome. Cardiovasc Pathol. 2017;30:78–81.
  • Hsu BS, Guillot M, Mosher J, et al. Case 5: chest pain and elevated troponin in a teenager. Pediatr Rev. 2017;38:388.
  • Toce MS, Farias M, Powell AJ, et al. Myocardial infarct after marijuana inhalation in a 16-year-old adolescent boy. Pediatr Dev Pathol. 2019;22:80-86.
  • Khalid S, Khalid A, Maroo P. Risk factors and management of takotsubo cardiomyopathy. Cureus. 2018;10:e2626.
  • Kariyanna PT, Jayarangaiah A, Hegde S, et al. Marijuana induced type I Brugada pattern: a case report. Am J Med Case Rep. 2018;6:134–136.
  • Opolski MP, Jaguszewski MJ, Spiewak M, et al. Optical coherence tomography for guiding plaque stabilization in a patient with myocardial infarction and massive coronary thrombosis. J Invasive Cardiol. 2018;30:E59–E60.
  • Wengrofsky P, Mubarak G, Shim A, et al. Recurrent STEMI precipitated by marijuana use: case report and literature review. Am J Med Case Rep. 2018;6:163–168.
  • Richards JR, Singh GD, Parikh AK, et al. Acute coronary syndrome after cannabis use: correlation with quantitative toxicology testing. Am J Emerg Med 2019;doi: 10.1016/j.ajem.2019.02.017. [Epub ahead of print]
  • Fisher-Hubbard AO, Kesha K, Diaz F, et al. Commode cardia-death by valsalva maneuver: a case series. J Forensic Sci. 2016;61:1541–1545.
  • ElSohly MA, Mehmedic Z, Foster S, et al. Changes in cannabis potency over the last 2 decades (1995-2014): analysis of current data in the United States. Biol Psychiatry. 2016;79:613–619.
  • Russo EB. Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol. 2011;163:1344–1364.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.